Champions Oncology (CSBR) Reports Q2 EPS of $0.03

December 16, 2019 4:10 PM EST

Champions Oncology (NASDAQ: CSBR) reported Q2 EPS of $0.03, versus $0.03 reported last year. Revenue for the quarter came in at $7.6 million, versus $6.7 million reported last year.

For earnings history and earnings-related data on Champions Oncology (CSBR) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings